Erschienen in:
01.06.2013 | Original Paper
Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report
verfasst von:
Wade Iams, Kathyrn Eby Beckermann, Anne T. Neff, Ingrid A. Mayer, Vandana Gupta Abramson
Erschienen in:
Medical Oncology
|
Ausgabe 2/2013
Einloggen, um Zugang zu erhalten
Abstract
Chemotherapy-induced thrombotic microangiopathy is a severe illness that has occurred in a small number of patients treated with carboplatin and combination of docetaxel and trastuzumab chemotherapy. We describe herein the case of a patient with stage IIB breast cancer who developed thrombotic microangiopathy after five cycles of carboplatin, docetaxel, and trastuzumab.